Mi
MiNA Therapeutics
London UKFounded 200850 employees
Private CapbiotechPrivateOncology
Platform: saRNA Upregulation
Market Cap
N/A
All Drugs
3
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zoriinavolisib | MIN-5044 | Phase 2/3 | 1 | WRN | MyelofibrosisPsA | ||
| MIN-2764 | MIN-2764 | Phase 3 | 1 | PCSK9 | PompeSLE | ||
| Talaosocimab | MIN-4238 | Phase 1 | 1 | RET | FSGSMCL |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)